AbbVie, Boehringer Ingelheim, and Pfizer were present at a clinical conference in Las Vegas.

The entities involved

• AbbVie →

  pharmaceutical company

  • AbbVie announced a joint development partnership with IGI, led by Lida Pacaud.Wed 17:17
  • Medicare eligibility rules affect AbbVie drug pricing, while the FDA regulates Creon's classification and approval for Medicare beneficiaries.Wed 16:42
• Boehringer Ingelheim →

  German pharmaceutical company

  • Matthew Hall serves as Executive Director of Corporate Development at Boehringer Ingelheim.Fri 19:07
• Pfizer →

  American multinational pharmaceutical and biotechnology corporation

  • Medicus Pharma secured an ADC development deal with Pfizer and is advancing its SkinJect 005 study for FDA approval.Sat 00:01
  • Major pharmaceutical companies licensed drug delivery technologies like Enhanze and Hypercon for various applications.Fri 16:54

Related events

• Bristol-Myers Squibb and AbbVie secured regulatory approval for a therapy in the US.Oct 21
• AbbVie, Eli Lilly, and Merck are broadening their therapeutic reach.Jun 8
• AbbVie and Abbott Laboratories are large healthcare companies whose corporate histories are linked by a major split that occurred in 2013.Jun 7
• AbbVie, Johnson & Johnson, Bristol-Myers Squibb, and Amgen are innovating targeted, cost-effective therapies for psoriatic arthritis.Jun 8
• AbbVie and others are managing drug exclusivity, seeking next-gen immunology pipeline growth, and competing for market share.Jun 22